Dr Chee Cheng Ean graduated from University College London (UCL) Medical School, London, UK with a Bachelor of Science (Hons) in Tumour Biology in 2001 and MBBS (Lond) in 2004. She then pursued her post-graduate training in the US by completing her residency in Internal Medicine (2008) and fellowship in Haematology and Oncology (2011) at the Mayo Clinic in Rochester, Minnesota. She was also appointed as Chief Fellow of the Mayo Clinic Haematology/Oncology Fellowship Program and promoted to Assistant Professor of Medicine and Oncology during her time at Mayo Clinic. Dr Chee subsequently joined the Division of Haematology/Oncology at Case Western Reserve University in Cleveland, Ohio, USA as an attending physician and Assistant Professor of Medicine.
Her clinical research portfolio includes a novel biomarker study in colorectal cancer which was awarded institutional and national grant funding. She also developed and was Principal Investigator and national study chair of a Phase I/II US cooperative group clinical trial of a Wee1 inhibitor in pancreas cancer which received full support and endorsement by the Eastern Cooperative Oncology Group (ECOG)-American College of Radiology Imaging Network (ACRIN) and Cancer Therapy Evaluation Program (CTEP) of the National Cancer Institute (NCI) in the US. Her work in pancreas cancer lead to her appointment as the ECOG representative to the Pancreatic Cancer Task Force of the NCI Gastrointestinal Steering Committee. She has many publications in peer-reviewed journals and has been invited as a journal reviewer in her field.
Dr Chee is a specialist in medical oncology and currently practices as a senior consultant medical oncologist and clinician scientist at the National University Cancer Institute, Singapore. She is board certified by the American Board of Internal Medicine (ABIM) in Internal Medicine, Medical Oncology and Haematology. Dr Chee’s interests are in cancers of the gastrointestinal (GI) tract which includes colorectal cancer, liver and pancreas cancers, cancers of the biliary tract, stomach and oesophageal cancers. She is also interested in drug development of novel agents and phase I trials.
Mary Hellerstein Junior Career Development Award, Case Western Reserve University, Cleveland, OH, USA (2014)
Louis Stokes Cleveland Veterans Affairs Medical Research and Foundation Grant, Cleveland, OH, USA (2012)
Case GI SPORE Career Development Award, Case Western Reserve University, Cleveland, OH, USA (2012)
Case GI SPORE Pilot Award, Case Western Reserve University, Cleveland, OH, USA (2012)
Chief Fellow, Haematology/Oncology, Mayo Clinic, Rochester, MN, USA (2010)
Merit Award, final MBBS exam, University College London Medical School, UK (2004)
Sir Thomas Lewis Prize in Cardiology, University College London, UK (2004)
Amulree Elective Scholarship Award, University College London Medical School, UK (2003)
Bernard Hart Prize in Clinical Neurosciences, University College London, UK (2003)
Merit Award, Year 3 University College London Medical School, UK (2002)
Tumour Biology Research Project Prize, University College London, UK (2001)
Wellcome Trust Research Scholarship, UK (2001)